XNYS
CDRE
Market cap1.23bUSD
Jul 09, Last price
29.56USD
1D
2.53%
1Q
-9.46%
IPO
93.20%
Name
Cadre Holdings Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Cadre Holdings, Inc. specializes in manufacturing and distributing vital safety and survival gear designed to protect individuals in perilous or life-threatening environments, both within the United States and globally. The company operates through two distinct divisions: its proprietary Products segment and a Distribution arm. Under its well-known Safariland and Protech Tactical brands, Cadre produces a wide array of body armor, encompassing discreet concealable vests, correctional facility-specific protection, and tactical models. Their extensive product line also features survival suits, remotely operated vehicles (ROVs), specialized tools, blast detection sensors, various ancillary items, vehicle blast attenuation seating for explosive ordnance disposal technicians, and full bomb suits. Furthermore, they supply essential duty equipment, such as belts and accessories, alongside other protective and law enforcement essentials, including communications systems, forensic investigation kits, firearm cleaning solutions, and crowd management apparatus. Beyond its own manufactured goods, Cadre also acts as a distributor for third-party products like uniforms, optical devices, footwear, firearms, and ammunition. Their clientele is diverse, primarily serving first responders such as state and local law enforcement, fire and rescue teams, explosive ordnance disposal (EOD) specialists, emergency medical technicians, fishing and wildlife enforcement agencies, and correctional departments. Additionally, federal agencies like the U.S. Departments of State, Defense, Interior, Justice, Homeland Security, and Corrections are among their customers, as are various international government bodies. Established in 1964, Cadre Holdings, Inc. maintains its corporate headquarters in Jacksonville, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||